Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease and ATM Mutation: A Case Report
ABSTRACT: Managing pediatric Crohn's disease (PCD) presents challenges due to severe complications and higher biologic therapy needs. Transitioning from anti–tumor necrosis factor agents to off-label therapies adds complexity. Although upadacitinib has demonstrated efficacy and tolerability in...
Saved in:
| Main Authors: | Yan Liu, MD, XiaoMei Song, MD, LingYa Xiang, MD, Wei Tan, MD, Min Zou, MD, Hong Guo, MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Current Therapeutic Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X24000262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel pathogenic ATM mutation with ataxia-telangiectasia in a Chinese family
by: Qiaomin Zhou, et al.
Published: (2024-11-01) -
Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn’s Disease: A Case Report
by: Michele Campigotto, et al.
Published: (2025-03-01) -
ATM is associated with the prognosis of colorectal cancer: a systematic review
by: Pei Wu, et al.
Published: (2025-03-01) -
Successful management of recurrent erythema multiforme with upadacitinib: A case report
by: Francelia Eckembrecher, MD, MPH, et al.
Published: (2025-06-01) -
Combination therapy of Crohn's disease with an interleukin 12/23
inhibitor and a targeted immunosuppressant: Clinical cases
by: Oleg V. Knyazev, et al.
Published: (2025-01-01)